Jenny Herman, the Senior Vice President and Controller at Schrodinger, Inc. (NASDAQ:SDGR), recently sold 859 shares of the company's common stock. The shares were sold at a price of $24.43 each ...

Xpeng (XPEV) and Schrodinger (SDGR) are climbing 5% and 3.3%, respectively, today after Nasdaq.com reported that institutions had acquired many more shares in the companies than they had sold in ...

Despite a decline in total revenue, Schrodinger Inc (SDGR) showcases robust software performance and strategic collaborations for future growth. NEW YORK, February 20, 2025--Schrödinger ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sarepta Therapeutics (SRPT – Research Report), ...

Schrodinger, Inc. (NASDAQ:SDGR), a pharmaceutical technology company with a market capitalization of $1.54 billion, announced on Monday the appointment of Bridget van Kralingen to its Board of ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Schrodinger demonstrated solid performance in Q4 2024, with total revenue for the year reaching $288 million, a significant increase from $217 million in 2023. The company experienced robust ...

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced that management will participate in the following conferences in March: The live discussions can be accessed in the ...

Schrodinger, Inc. (NASDAQ:SDGR), a pharmaceutical technology company with a market capitalization of $1.54 billion, announced on Monday the appointment of Bridget van Kralingen to its Board of ...